Page last updated: 2024-12-06
methyl tetradecanoate
Description
Methyl tetradecanoate, also known as myristate, is a fatty acid methyl ester that occurs naturally in various plants and animals. It is synthesized by the esterification of myristic acid with methanol. Methyl tetradecanoate is a colorless, odorless liquid with a melting point of -1°C and a boiling point of 295°C. It is used in the production of various cosmetics, pharmaceuticals, and food additives. Methyl tetradecanoate is also a potential biofuel due to its high energy content and low viscosity. It is studied for its potential applications in various industries, including cosmetics, pharmaceuticals, and biofuel production. The compound is also investigated for its potential effects on human health, including its role in lipid metabolism and its potential benefits for skin health.'
```
methyl tetradecanoate: component of fabric detergents [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
methyl tetradecanoate : A fatty acid methyl ester resulting from the formal condensation of the carboxy group of tetradecanoic acid (myristic acid) with methanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 31284 |
| CHEMBL ID | 207549 |
| CHEBI ID | 89199 |
| SCHEMBL ID | 158121 |
| MeSH ID | M0495592 |
Synonyms (66)
| Synonym |
|---|
| methyl myristate |
| methyl tetradecanoate |
| myristic acid, methyl ester |
| tetradecanoic acid, methyl ester |
| 124-10-7 |
| nsc-5029 |
| methyl n-tetradecanoate |
| metholeneat 2495 |
| uniphat a50 |
| nsc5029 |
| methyl myristate, >=99% (gc) |
| methyl myristate, >=98%, fg |
| NCGC00164312-01 |
| F205A716-B088-445E-981A-7037783C0147 |
| tetradecanoic acid methyl ester (fame mix) |
| myristic acid methyl ester |
| chebi:89199 , |
| CHEMBL207549 |
| tetradecanoic acid methyl ester |
| M0482 |
| AKOS004910358 |
| NCGC00164312-02 |
| LMFA07010467 |
| we(1:0/14:0) |
| cas-124-10-7 |
| tox21_200012 |
| dtxcid607019 |
| NCGC00257566-01 |
| dtxsid5027019 , |
| FT-0686716 |
| ec 204-680-1 |
| nsc 5029 |
| einecs 204-680-1 |
| fema no. 2722 |
| unii-rg9851783c |
| hsdb 5602 |
| ai3-01980 |
| rg9851783c , |
| methyl myristate [hsdb] |
| methyl myristate [usp-rs] |
| methyl myristate [fhfi] |
| methyl myristate [inci] |
| SCHEMBL158121 |
| methyltetradecanoate |
| methyl myristylate |
| emery 2214 |
| acide myristique methyl ester |
| mfcd00008983 |
| formyl tetradecanoate |
| STL453780 |
| J-005043 |
| methyl myristate, analytical standard |
| methyl myristate, united states pharmacopeia (usp) reference standard |
| methyl myristate, certified reference material, tracecert(r) |
| tetradecanoic acid-methyl ester |
| c14 fame |
| CS-W004288 |
| methylmyristate |
| myristic acid, methyl ester (8ci) |
| methyl-myristate |
| Q27161384 |
| 2,6-dimethylbenzeneboronicacid |
| H10750 |
| methyl tetradecanoate; methyl myristate 99%; myristic acid methyl ester; tetradecanoic acid methyl ester |
| A890596 |
| HY-W004288 |
Roles (3)
| Role | Description |
|---|
| plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
| flavouring agent | A food additive that is used to added improve the taste or odour of a food. |
| fragrance | A substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
| Class | Description |
|---|
| fatty acid methyl ester | A fatty acid ester that is the carboxylic ester obtained by the formal condensation of a fatty acid with methanol. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein Targets (3)
Potency Measurements
Bioassays (3)
| Assay ID | Title | Year | Journal | Article |
|---|
| AID264976 | Antibacterial activity against Staphylococcus aureus | 2006 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
| Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives. |
| AID264977 | Antibacterial activity against Micrococcus luteus | 2006 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
| Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives. |
| AID264978 | Antibacterial activity against Escherichia coli | 2006 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
| Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 38.33
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 38.33 (24.57) | | Research Supply Index | 1.95 (2.92) | | Research Growth Index | 4.28 (4.65) | | Search Engine Demand Index | 46.12 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |